As a result, Novo Nordisk has dropped the lawsuit it filed against Hims & Hers in February
When expanding trial eligibility criteria to reflect broader patient populations typically encountered in clinical practice, we identified 453,201 individuals initiating semaglutide or sitagliptin (expanding SUSTAIN-6 eligibility) and 136,089 initiating tirzepatide or dulaglutide (expanding SURPASS-CVOT eligibility)
Both can be prescribed by primary care physicians, endocrinologists, obesity medicine specialists, or through telehealth platforms like TrimRx
Dose Adjustments : Gradual dosage increases allow the body to adapt, reducing the risk of side effects like body aches
[1] Key points: Dose: 25mg daily tablet (vs 2.4mg weekly injection) How to take: On empty stomach with small sip of water, 30 min before food Weight loss: ~14% at 68 weeks (comparable to injection) [5] Price: Same as injection (~$1,349/month list) There is no oral Ozempic